Indian firm Bharat Biotech’s Covaxin to start human trial

Indian firm Bharat Biotech’s Covaxin to start human trial

Bharat Biotech’s Covid vaccine candidate Covaxin is set to undergo human clinical trials in July. It was developed at the firm’s Genome Valley plant in Hyderabad, in collaboration with the ICMR. Krishna Ella, chairman and managing director of Bharat Biotech, said that they are proud to announce Covaxin, India’s first indigenous vaccine for Covid-19 as it enters the human clinical trial stage.

Milan
Milan
Aswin
Aswin 6 days

Great ! every step, no matter how small is important in fighting this virus, it’s not USA/India/EU vs. the virus , is humanity 🆚 this virus . Let’s hope we find a vaccine soon.

Top in Business
Get the App